Financings in Brief: Female Health Company
This article was originally published in The Gray Sheet
Female Health Company: Raises approximately $3 mil. in secondary offering of about 700,000 shares at $4.40 each. The Chicago-based manufacturer of the Reality female condom says the financing allowed it to pay off a $484,000 note relating to the firm's February 1996 acquisition of Chartex International ("The Gray Sheet" Dec. 4, 1995, I&W-8). The proceeds also "will allow the company to enter into a sale/lease-back of its London manufacturing facility," FHC says, adding: "The funds raised, together with improved cash flow due to increasing revenue, especially from Korea, enable the company to continue its development of the only female condom available on a global basis"...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.